Results 171 to 180 of about 3,056 (181)

Correction: Donanemab: First Approval

Drugs
openaire   +1 more source

Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction

Alzheimer's and Dementia
Emily C Collins, Dawn A Brooks, John R Sims   +2 more
exaly  

Donanemab-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer’s disease

Journal of Basic and Clinical Physiology and Pharmacology
Ajay Kumar Shukla
exaly  

TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease

Alzheimer's and Dementia
exaly  

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study

Clinical Pharmacology in Drug Development
exaly  

Alzheimertherapie: FDA-Zulassung für Donanemab

InFo Neurologie + Psychiatrie
openaire   +1 more source

Donanemab gegen frühe Alzheimerkrankheit zugelassen

NeuroTransmitter
openaire   +1 more source

Zulassung für Donanemab zur Alzheimertherapie

DNP – Die Neurologie & Psychiatrie
openaire   +1 more source

Donanemab erhält positive CHMP-Empfehlung

InFo Neurologie + Psychiatrie
openaire   +1 more source